This question and answer document answers common questions and concerns that family members have about Medication Assisted Treatment (MAT). The purpose of this document is to assist providers in educating family members.
Patients can use this Early Recovery Handout to determine behaviors when cravings or urges arise or behaviors have changed. The document provides strategy to mitigate any behavioral outliers while keeping the patient on track from day to day.
This article reviews research findings in the following 7 areas: location of buprenorphine induction, combining buprenorphine with a benzodiazepine, relapse during buprenorphine treatment, requirements for counseling, uses of drug testing, use of other substances during buprenorphine treatment, and duration of buprenorphine treatment.
The Medication-Assisted Treatment Of Opioid Use Disorder pocket guide to provide guidance on how to assess the need for treatment, referring to higher levels of care if necessary and the approved frequency and route of administration for treatment of Opioid Use Disorder. In addition, a tool has been provided to determine clinical opiate withdrawal.
The Substance Abuse and Mental Health Services Administration provides guidance for substance use disorder treatment services during the COVID-19 pandemic. The document specifies when a medical emergency exists, 42 C.F.R Part 2 does not apply and any disclosure of medical information is temporarily exempt for purposes of medical treatment.
The frequently asked questions document discusses how providers can provide Opioid Treatment to existing and new patients, and dispense medications via Telehealth while still meeting the 42 C.F.R. 8.11 requirements.
The frequently asked question document makes recommendations on how to care for patients during the COVID-19 pandemic in Mental Health Rehabilitation Centers and Psychiatric Health facilities. The recommendations suggest how to provide Telehealth services, and how to provide medical care for positive COVID-19 patients.
This document is a resource for behavioral health facilities to better understand how to treat patients and refer patients for medical care during the COVID-19 pandemic.
During the webinar, the presenter will focus on ways to address health equity issues and key considerations for providing linguistically effective services. The presenter will discuss best practices and models to support patients in these challenging times.
Understanding the brain chemistry associated with opioid use disorder treatment is essential: Medications for Addiction Treatment (MAT) restores depleted dopamine in the brain so people impacted by OUD can regain functioning. Recognizing this, therapy and support services for OUD are most effective when provided in accordance with a person's healing process and readiness to engage in treatment.
The American Society of Addiction Medicine (ASAM) has established specific criteria for patient assessments and level of care determinations pertaining to substance use disorder (SUD) – providing the underpinnings for effective treatment and recovery from addiction. This webinar will provide attendees with practical tools and tips for implementation of Screening Brief Intervention and Treatment (SBIRT) including assessments, workflows, and reimbursement.
This webinar will describe how stigma impacts perceptions and resultant SUD care for patients and providers alike. Presenters will also share key concepts and case studies to illustrate ways to address stigma and tools that can be incorporated into their clinical practice.
This webinar will focus on the benefits and outcomes of behavioral health integration and key implementation considerations. The presenters will discuss outcomes that include improving population health, patient experience and reduced costs. The webinar will also feature key integration tips such as building internal support, warm handoffs, establishing workflows among other topics.
This webinar will focus on the foundational concepts of health care integration – including physical and behavioral health – will be reviewed and discussed. The presenters will also focus on integrating substance use disorders and reverse integration.
This module offers a 25-minute video of the neuroscience of addiction as a chronic brain disease presented by HMA’s Corey Waller, MD, MS, FACEP, DFASAM, with emphasis on Opioid Use Disorder (OUD).
"This lecture was developed for audiences of all backgrounds to absorb. From patients to nonspecialist docs. The intent was to move people past the preconceived notion that addiction is a moral failing or choice, to the reality that it is a chronic brain disease that creates maladaptive connections in large swaths of the brain. Over the hundreds of lectures, I have given in my career, I have come to realize that running through 30+ articles in a 70 slide PPT does not move people emotionally. But a good story will. The lecture has coalesced into a story form that is much more compelling than digging through the dense science of voxel dysmorphology, BOLD fMRI technology, and all of the structures postulated to drive craving. If I need a custody officer to "get it" or an administrator to understand the concept, I cannot give them the same lecture I would give a psychiatrist, addiction psychologist, addiction doc, or a neurologist."
"The systemic approach to providing person-centered care for a defined population that coordinates physical and behavioral healthcare through a team of primary care and behavioral health practitioners, working with the individuals served, families, and other natural and informal supports.
Integrated care models ensure that mental health, substance use disorder, primary care, and specialty services are coordinated and delivered in a manner that is most effective to care for individuals with multiple health care needs and produces the best outcomes."
Deeper dive on the operational practicalities of delivering MAT and other SUD treatment to clients through telehealth and other remote means; risk and management of relapse and overdose; current expectations regarding privacy rules, documentation, and new regulations from the DEA.
The webinar presents policy and reimbursement implications for changes regarding Medicare and Medicaid and the impacts on key provider decisions concerning selecting, implementing, and building a business case for new telehealth services to support patients in these challenging times.
This webinar focused on the appropriate screening and assessments for substance use disorders, including the difference between screening and assessment, brief interventions for substance-related issues, and medications for opioid use disorder.
An overview of health literacy, its impact on health outcomes, challenges facing patients, and health literacy resources and tips for communicating with patients.
This webinar includes a refresher on motivational Interviewing, presented tools to strengthen patient engagement and strategies for enhancing and maintaining clinician capacity to work with consistency, presence, and joy in the work.
This webinar presented the Stepped Care Approach, including validated screening tools, strategies and resources for patients with mild, moderate or urgent behavioral health care needs.